Natera (NTRA) Stock Forecast & Price Target

NTRA$391.03—
Medical - Diagnostics & ResearchLarge CapGrowth Stock
Compare
Market cap$39.64BEnterprise value—Revenue (TTM)$2.91BMarket positionTop 25%

Score

56
Neutral
Value
52
Quality
27
Growth
88

Natera, Inc. price target

NTRA
Low$245.00
Median$407.50
High$500.00
Upside vs current price+4.2%

The median target of $407.50 is +4.2% versus the current NTRA price of $391.03.

Natera, Inc. analyst ratings

RatingAnalysts
Strong buy4
Buy17
Hold2
Sell0
Strong sell0
ConsensusBuy

23 analysts cover NTRA.

Natera, Inc. EPS and revenue estimates

NTRA shows the next fiscal years with at least three analysts: 2026 EPS $-1.45, 2027 EPS $-0.37. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-1.45$2.91B
2027$-0.37$3.52B

Is Natera, Inc. a buy or sell?

Of the 23 analysts covering Natera, Inc., 21 rate it a buy (4 strong buy and 17 buy), 2 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The NTRA consensus label is Buy, beside 21 buy-side ratings and 0 sell-side ratings.

The median target of $407.50 implies +4.2% versus the current price of $391.03.

Those 23 ratings on NTRA are a headcount, and the label on file is Buy.

Reading the Natera, Inc. forecast

The NTRA target range is wide: $245.00 at the low end, $407.50 in the middle, and $500.00 at the top.

Set next to the $391.03 NTRA quote, that median is +4.2%.

Ratings on the Natera, Inc. cluster: 21 of 23 analysts are on the buy side, 2 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The average NTRA target over the last month is $430.00, below the $452.22 quarterly average.

16 firms published targets on NTRA, so one note does not swing the median by itself.

Natera, Inc. forecast questions

What is the NTRA price target?

The published range for NTRA is $245.00 to $500.00, with a median target of $407.50. That median is +4.2% versus the current price of $391.03.

Is Natera, Inc. a buy or sell?

Of the 23 analysts covering Natera, Inc., 21 rate it a buy, 2 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the NTRA headcount is 21 buy, 2 hold, and 0 sell.

What is the EPS estimate for Natera, Inc.?

Analyst EPS estimates for Natera, Inc.: 2026 $-1.45, 2027 $-0.37.

What is the revenue estimate for Natera, Inc.?

Analyst revenue estimates for Natera, Inc.: 2026 $2.91B, 2027 $3.52B.

How many analysts cover NTRA?

23 analysts cover NTRA. Their consensus on NTRA is Buy, across those 23.

NTRA price $391.03 —

Insights · Forecast · Financials · Learn

Stocklytics home · Screener